Asset Details
Do you wish to reserve the book?
The Effect of Antifibrotic Drugs in Rat Precision-Cut Fibrotic Liver Slices
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The Effect of Antifibrotic Drugs in Rat Precision-Cut Fibrotic Liver Slices
Do you wish to request the book?
The Effect of Antifibrotic Drugs in Rat Precision-Cut Fibrotic Liver Slices
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The Effect of Antifibrotic Drugs in Rat Precision-Cut Fibrotic Liver Slices
2014
Overview
Two important signaling pathways in liver fibrosis are the PDGF- and TGFβ pathway and compounds inhibiting these pathways are currently developed as antifibrotic drugs. Testing antifibrotic drugs requires large numbers of animal experiments with high discomfort. Therefore, a method to study these drugs ex vivo was developed using precision-cut liver slices from fibrotic rat livers (fPCLS), representing an ex vivo model with a multicellular fibrotic environment. We characterized the fibrotic process in fPCLS from rat livers after 3 weeks of bile duct ligation (BDL) during incubation and tested compounds predominantly inhibiting the TGFβ pathway (perindopril, valproic acid, rosmarinic acid, tetrandrine and pirfenidone) and PDGF pathway (imatinib, sorafenib and sunitinib). Gene expression of heat shock protein 47 (Hsp47), α smooth muscle actin (αSma) and pro-collagen 1A1 (Pcol1A1) and protein expression of collagens were determined. During 48 hours of incubation, the fibrosis process continued in control fPCLS as judged by the increased gene expression of the three fibrosis markers, and the protein expression of collagen 1, mature fibrillar collagen and total collagen. Most PDGF-inhibitors and TGFβ-inhibitors significantly inhibited the increase in gene expression of Hsp47, αSma and Pcol1A1. Protein expression of collagen 1 was significantly reduced by all PDGF-inhibitors and TGFβ-inhibitors, while total collagen was decreased by rosmarinic acid and tetrandrine only. However, fibrillar collagen expression was not changed by any of the drugs. In conclusion, rat fPCLS can be used as a functional ex vivo model of established liver fibrosis to test antifibrotic compounds inhibiting the PDGF- and TGFβ signalling pathway.
Publisher
Public Library of Science,Public Library of Science (PLoS)
Subject
/ Actin
/ Animals
/ Bile
/ Cell Survival - drug effects
/ Collagen
/ Collagen Type I - metabolism
/ Cytological Techniques - methods
/ Drugs
/ Fibrosis
/ Gene Expression Regulation - drug effects
/ Imatinib
/ Kinases
/ Liver
/ Liver Cirrhosis - drug therapy
/ Male
/ Medicine and Health Sciences
/ Muscles
/ Platelet-derived growth factor
/ Platelet-Derived Growth Factor - antagonists & inhibitors
/ Platelet-Derived Growth Factor - metabolism
/ Research and Analysis Methods
/ Rodents
/ Transforming Growth Factor beta - antagonists & inhibitors
